Collection's Items (Sorted by Submit Date in Descending order): 121 to 140 of 960
| Issue Date | Title | Author(s) |
| 2024-06 | A structure-based pharmacophore modelling approach to identify and design new neprilysin (NEP) inhibitors: an in silico-based investigation | Gaikwad, Anil Bhanudas; Jadhav, Hemant R. |
| 2024-07 | Design, synthesis and evaluation of new methyl piperazine derivatives as anticancer agents | Jadhav, Hemant R. |
| 2025 | Principles of research methodology and ethics in pharmaceutical sciences: an application guide for students and researchers | Jadhav, Hemant R. |
| 2024-09 | Structural considerations and chemistry of protacs | Jadhav, Hemant R. |
| 2024-09 | Computational Analysis of Phase I Metabolism in Clinically Studied Flavoalkaloids: Molecular Docking, MMGBSA Binding Energy Calculations, and Molecular Dynamics Simulations | Jadhav, Hemant R. |
| 2024-12 | A perspective on the development of small molecular neprilysin inhibitors (NEPi) with emphasis on cardiorenal disease | Jadhav, Hemant R.; Gaikwad, Anil Bhanudas |
| 2024-05 | Structure-based virtual screening of FDA-approved drugs to discover potential inhibitors of phosphoinositide kinase, PIKfyve | Jadhav, Hemant R. |
| 2024-12 | Structure-based virtual screening and biological characterization of novel bace-1 and amyloid-β aggregation inhibitors | Jadhav, Hemant R. |
| 2024-12 | Recent advancements in the therapeutic approaches for Alzheimer's disease treatment: current and future perspective | Jadhav, Hemant R. |
| 2025-01 | Unfolding the Potential of Pyrrole- and Indole-Based Allylidene Hydrazine Carboximidamides as Antimicrobial Agents | Jadhav, Hemant R.; Jha, Prabhat Nath |
| 2025-01 | Novel therapeutic targets for cardiorenal syndrome | Jadhav, Hemant R.; Gaikwad, Anil Bhanudas |
| 2024-05 | Lipo-polymeric nano-complexes for dermal delivery of a model protein | Chitkara, Deepak |
| 2024 | Restoring physiological parameters of the pancreas and kidney through treatment with a polymeric nano-formulation of C-peptide and lisofylline combination in diabetic nephropathy | Chitkara, Deepak |
| 2024 | Next-generation CRISPR/Cas-based ultrasensitive diagnostic tools: current progress and prospects | Chitkara, Deepak |
| 2024-11 | Neurotensin conjugated polymeric porous microparticles suppress inflammation and improve angiogenesis aiding in diabetic wound healing | Chitkara, Deepak |
| 2024-02 | Macrophage derived Exosomal Docetaxel (Exo-DTX) for pro-metastasis suppression: QbD driven formulation development, validation, in-vitro and pharmacokinetic investigation | Chitkara, Deepak |
| 2024-06 | cRGD-modified hybrid lipopolymeric nanoplexes for gene editing in the posterior segment of the eye | Chitkara, Deepak |
| 2024-09 | Exosomal fragment enclosed polyamine-salt nano-complex for co-delivery of docetaxel and mir-34a exhibits higher cytotoxicity and apoptosis in breast cancer cells | Chitkara, Deepak |
| 2024-11 | Downregulation of microRNA-29b in cancer and fibrosis: molecular insights and clinical implications | Chitkara, Deepak |
| 2024-10 | Potent anti-inflammatory and anti-apoptotic activities of electrostatically complexed C-peptide nanospheres ameliorate diabetic nephropathy | Chitkara, Deepak |
Collection's Items (Sorted by Submit Date in Descending order): 121 to 140 of 960
